Arbitration and Other ADR
About
Sidestepping costly choices to find better answers
Finnegan has one of the strongest reputations for litigating IP disputes through trial and appeal. But when circumstances merit its use, we favor alternative dispute resolution (ADR). We often develop a litigation strategy designed to meet goals through ADR instead of trial.
Contacts
- Gary C. Ma
- Partner
- Taipei
- +886 2 2712 7001
- Ningling Wang
- Partner
- Shanghai
- +86 21 6194 2005
Experience
Represented CSRC in two arbitrations and one litigation relating to exclusive licenses and patent assignments for patents directed to treating Pompe Disease, a rare genetic disorder that is often fatal if untreated. Secured a $180 million settlement from Genzyme.
01-19-0001-6937; 01-20-0000-5081, AAA
Represented a major U.S. pharmaceutical company in two arbitrations concerning a leading biologic. Finnegan’s client won both arbitrations and, in the second, was awarded its attorney fees.
Represented a U.S. pharmaceutical company in an arbitration with a former consultant and inventor. The dispute involved issues relating to inventorship and ownership, as well as the determination of royalties due under various agreements. The matter settled shortly before the hearing on favorable terms.
Member of team that represented AbbVie Biotechnology Ltd. and Abbott GmbH in a WIPO arbitration related to patent licensing.
WIPOA120712, WIPO
Counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and appeal.
16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer
Guided Anoto through a successful European arbitration proceeding to enforce a supply agreement for a critical component of Anoto’s products, and then spearheaded a successful effort to enforce the arbitrator’s decision in the United States.
3:16-cv-06209, N.D. Cal., Judge Tigar
